China Approves First mRNA Vaccine After Covid Wave Ebbs
- Domestic firm CSPC gets emergency use nod for Covid mRNA shot
- Shot shows high efficacy in booster trial with little detail
This article is for subscribers only.
China approved its first messenger RNA vaccine for Covid-19, clearing a shot from a local drugmaker that harnesses the powerful technology months after the world’s most-populous nation abandoned pandemic curbs.
The mRNA vaccine, developed by CSPC Pharmaceutical Group Ltd. and which targets the omicron variant, has been approved for emergency use, according to a statement from the company Wednesday to the Hong Kong stock exchange. Shares extended intraday gains to 7.7% before quickly paring most of that advance to trade 2.6% higher as of 1:15 pm in Hong Kong.